UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 163

Sortiert nach

Talimogene Laherparepvec (T-VEC): A Review of the Recent Advances in Cancer Therapy

Journal of clinical medicine, 2023-01, Vol.12 (3), p.1098

2023

Volltextzugriff (PDF)

Targeting Wnt signaling for improved glioma immunotherapy

Frontiers in immunology, 2024-02, Vol.15, p.1342625-1342625

2024

Volltextzugriff (PDF)

RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5

Blood, 2011-04, Vol.117 (14), p.3847-3857

2011

Volltextzugriff (PDF)

Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells

Oncotarget, 2017-02, Vol.8 (7), p.12234-12246

2017

Volltextzugriff (PDF)

Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies

Journal for immunotherapy of cancer, 2024-07, Vol.12 (7), p.e008505

2024

Volltextzugriff (PDF)

Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models

International journal of molecular sciences, 2020-10, Vol.21 (19), p.7326

2020

Volltextzugriff (PDF)

Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer

Breast cancer research : BCR, 2019-11, Vol.21 (1), p.119-13, Article 119

2019

Volltextzugriff (PDF)

High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes

SLAS discovery, 2022-01, Vol.27 (1), p.68-76

2022

Volltextzugriff (PDF)

STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma

Genome medicine, 2014-01, Vol.6 (1), p.9-9, Article 9

2014

Volltextzugriff (PDF)

A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters

Journal of the American Chemical Society, 2016-10, Vol.138 (41), p.13673-13692

2016

Volltextzugriff (PDF)

Abstract 6397: Focal adhesion kinase (FAK) inhibition overcomes cisplatin resistance in head and neck squamous cell carcinoma (HNSCC)

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6397-6397

2020

Volltextzugriff (PDF)

Abstract 1525: Upregulation of genes linked to epithelial-mesenchymal transition in anaplastic thyroid cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.1525-1525

2020

Volltextzugriff (PDF)

Differential immune pathways in classic and mixed variants of anaplastic thyroid cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e18579-e18579

2020

Volltextzugriff (PDF)

Abstract 4910: Development of an antagonist to the TWEAK-Fn14 ligand-receptor interaction with enhanced efficacy/potency in glioblastoma cells

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.4910-4910

2018

Volltextzugriff (PDF)

Abstract 528: Radioembolization followed by durvalumab and tremelimumab does not induce immune responses against liver-metastasized MSS colorectal cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.528-528

2019

Volltextzugriff (PDF)

Abstract 5564: Dual inhibition of TTK and HSPA9 functions to synergistically decrease viability in triple-negative breast cancer cell lines

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5564-5564

2014

Volltextzugriff (PDF)

Gene expression profiling of unresectable pancreatic cancer patients treated with gemcitabine, nab-paclitaxel, metformin, and dietary supplements (DS)

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.736-736

2020

Volltextzugriff (PDF)

Abstract B13: Pilot trial of gemcitabine, nab-paclitaxel, metformin, and a standardized dietary supplement in patients with unresectable pancreatic cancer

Cancer research (Chicago, Ill.), 2019-12, Vol.79 (24_Supplement), p.B13-B13

2019

Volltextzugriff (PDF)

In vitro small molecule screening to inform novel candidates for use in fluconazole combination therapy in vivo against Coccidioides

Microbiology spectrum, 2024-08, p.e0100824

2024

Volltextzugriff (PDF)

Development and validation of an α3β4 nicotinic acetylcholine receptor (nAChR) high-throughput screening- (HTS-) ready assay

Biochemical pharmacology, 2015-10, Vol.97 (4), p.622-623

2015

Volltextzugriff (PDF)

Abstract 1238: Targeting the platelet derived growth factor receptor (PDGFR) with the receptor tyrosine kinase inhibitor ponatinib in small cell carcinoma of the ovary, hypercalcemic type

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1238-1238

2017

Volltextzugriff (PDF)

Abstract NTOC-090: TARGETING AND EFFICACY OF THE RECEPTOR TYROSINE KINASE INHIBITOR PONATINIB IN SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE, WORKS THROUGH INHIBITION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR)

Clinical cancer research, 2017-06, Vol.23 (11_Supplement), p.NTOC-090-NTOC-090

2017

Volltextzugriff (PDF)

Abstract 2709: Identification of Aurintricarboxylic Acid (ATA) as an inhibitor of TWEAK-Fn14 signaling in glioblastoma cells

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2709-2709

2014

Volltextzugriff (PDF)

Abstract LB-217: CK2 protein kinase promotes resistance to MAPK pathway inhibition

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.LB-217-LB-217

2014

Volltextzugriff (PDF)

Abstract PR4: Dual inhibition of TTK and HSPA9 functions to synergistically decrease viability in triple-negative breast cancer cell lines

Cancer epidemiology, biomarkers & prevention, 2014-11, Vol.23 (11_Supplement), p.PR4-PR4

2014

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(152)

Publikationsform

Sprache

Englisch
(163)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(90)
Life Sciences & Biomedicine
(75)
Humans
(58)
Female
(29)
Male
(25)
Animals
(23)
Adult
(21)
Oncology
(16)
Mice
(15)
Biological And Medical Sciences
(13)
Middle Aged
(13)
Medical Sciences
(12)
Physical Sciences
(10)
Science & Technology - Other Topics
(10)
Aged
(8)
Cancer
(8)
Clinical Trials
(8)
Multidisciplinary Sciences
(8)
Patients
(8)
Tumors
(8)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(23)
Blood
(13)
Clinical Cancer Research
(6)
Molecular Cancer Therapeutics
(5)
Neuro-Oncology
(3)
Oncotarget
(3)
Biochemical Pharmacology
(2)
Biology Of Blood And Marrow Transplantation
(2)
Biomaterials
(2)
Cancer
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Talimogene Laherparepvec (T-VEC): A Review of the Recent Advances in Cancer Therapy

Targeting Wnt signaling for improved glioma immunotherapy

RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5

Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells

Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies

Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models

Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer

High-throughput cell-based assays for identifying antagonists of multiple smoking-associated human nicotinic acetylcholine receptor subtypes

STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma

A Pharmacological Chaperone Molecule Induces Cancer Cell Death by Restoring Tertiary DNA Structures in Mutant hTERT Promoters

Abstract 6397: Focal adhesion kinase (FAK) inhibition overcomes cisplatin resistance in head and neck squamous cell carcinoma (HNSCC)

Abstract 1525: Upregulation of genes linked to epithelial-mesenchymal transition in anaplastic thyroid cancer

Differential immune pathways in classic and mixed variants of anaplastic thyroid cancer

Abstract 4910: Development of an antagonist to the TWEAK-Fn14 ligand-receptor interaction with enhanced efficacy/potency in glioblastoma cells

Abstract 528: Radioembolization followed by durvalumab and tremelimumab does not induce immune responses against liver-metastasized MSS colorectal cancer

Abstract 5564: Dual inhibition of TTK and HSPA9 functions to synergistically decrease viability in triple-negative breast cancer cell lines

Gene expression profiling of unresectable pancreatic cancer patients treated with gemcitabine, nab-paclitaxel, metformin, and dietary supplements (DS)

Abstract B13: Pilot trial of gemcitabine, nab-paclitaxel, metformin, and a standardized dietary supplement in patients with unresectable pancreatic cancer

In vitro small molecule screening to inform novel candidates for use in fluconazole combination therapy in vivo against Coccidioides

Development and validation of an α3β4 nicotinic acetylcholine receptor (nAChR) high-throughput screening- (HTS-) ready assay

Abstract 1238: Targeting the platelet derived growth factor receptor (PDGFR) with the receptor tyrosine kinase inhibitor ponatinib in small cell carcinoma of the ovary, hypercalcemic type

Abstract NTOC-090: TARGETING AND EFFICACY OF THE RECEPTOR TYROSINE KINASE INHIBITOR PONATINIB IN SMALL CELL CARCINOMA OF THE OVARY, HYPERCALCEMIC TYPE, WORKS THROUGH INHIBITION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR)

Abstract 2709: Identification of Aurintricarboxylic Acid (ATA) as an inhibitor of TWEAK-Fn14 signaling in glioblastoma cells

Abstract LB-217: CK2 protein kinase promotes resistance to MAPK pathway inhibition

Abstract PR4: Dual inhibition of TTK and HSPA9 functions to synergistically decrease viability in triple-negative breast cancer cell lines

Suchergebnisse filtern